FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Delayed Deutsche Boerse AG 18:50:28 03/06/2024 BST | ||
| 63.96 EUR | +1.12% |
|
| 1 month | -2.07% | ||
| 3 months | +81.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 63.96 | +1.12% |
| 31/05/24 | 63.25 | +7.44% |
| 30/05/24 | 58.87 | +5.88% |
| 29/05/24 | 55.6 | -5.15% |
| 28/05/24 | 58.62 | -7.93% |
Delayed Quote Deutsche Boerse AG
Last update June 03, 2024 at 06:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PG8QDG |
| ISIN | DE000PG8QDG4 |
| Date issued | 07/11/2023 |
| Strike | 142 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 133.1 € |
|---|---|
| Lowest since issue | 28.74 € |
| Spread | 1.98 € |
| Spread % | 3.01% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
142
USD
Average target price
147
USD
Spread / Average Target
+3.54%
- Stock Market
- Certificates
- Certificat
